tradmap

INVX Financials Innovex International, Inc.

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 23.9% per year over the past 5 years.
  • Operating margin has expanded, at 13.6% in the latest year.
  • Free cash flow has grown 26.3% per year over the past 5 years.

Financial health

  • Operating income covered interest expense 51× in the latest year, up from -102.3× 5 years ago.
Revenue & net income
-$128M $425M $978M $0 2011 2013 2015 2017 2019 2021 2023 2025
RevenueNet income
Margins (gross / operating / net)
-45% -5% 35% 0% 2011 2013 2015 2017 2019 2021 2023 2025
GrossOperatingNet
Return on equity & assets (ROE / ROA)
-71% -23% 25% 0% 2011 2013 2015 2017 2019 2021 2023 2025
ROEROA
Free cash flow (CFO − capex)
-$59M $81M $221M $0 2011 2013 2015 2017 2019 2021 2023 2025
Free cash flow
Cash vs total debt
$0 $247M $493M 2011 2013 2015 2017 2019 2021 2023 2025
CashTotal debt
Cash flow: operating / investing / financing
-$187M $30M $247M $0 2011 2013 2015 2017 2019 2021 2023 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MROEROAFCFTotal debtCash
2025 $978M $83M 31.0% 13.6% 7.9% 6.6% — — $203M
2024 $661M $140M 35.2% 7.4% 14.6% 11.7% — $25M $73M
2023 $556M $74M 35.2% 17.5% 22.5% 15.6% $43M — $7M
2022 $467M $63M 33.8% 16.2% 25.2% 6.5% -$25M — $265M
2021 $288M -$128M -7.4% -43.5% -71.2% -12.7% $28M — $355M
2020 $334M -$31M 19.4% -19.0% -3.0% -2.7% -$33M — $346M
2019 $375M $2M 21.4% 0.7% 0.2% 0.1% $3M — $399M
2018 $337M -$96M 13.0% -36.4% -8.7% -8.0% $13M — $418M
2017 — -$101M — — -7.8% -7.2% $80M — $493M
2016 — $93M — — 6.9% 6.4% $221M — $423M
2015 — $192M — — 14.5% 13.4% $163M — —
2014 — $209M — — 16.8% 14.4% $107M — —
2013 — $170M — — 13.7% 12.2% $120M — —
2012 — $119M — — 11.2% 9.5% -$59M — —
2011 — $95M — — 10.3% 8.8% $46M $57000 —

Valuation over time

How the market has priced INVX against its own fundamentals since 2024-09 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 12.7 25.3 Sep '24 Jan '25 May '25 Sep '25 Jan '26 May '26 Sep '26
P/E
Price / sales (P/S)
0.0 1.2 2.3 Sep '24 Jan '25 May '25 Sep '25 Jan '26 May '26 Sep '26
P/S
Dividend yield (%)
0.0 3.9 7.8 Sep '24 Jan '25 May '25 Sep '25 Jan '26 May '26 Sep '26
Dividend yield %

Frequently asked questions

Is INVX growing its revenue and profit?

Over the past 5 years, Innovex International, Inc.'s revenue has grown 23.9% per year. These are computed facts, not advice.

How much debt does INVX have?

As of FY2025, Innovex International, Inc. reported — of total debt against $203M of cash; operating income covered interest expense 51×.

What is INVX's profit margin?

In FY2025, gross margin was 31.0%, operating margin 13.6%, and net margin 8.5%.

What is INVX's P/E ratio?

Innovex International, Inc.'s P/E (TTM) is 29.59 as of the 2026-11-02 close — market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year, the same figure as on the INVX stock page. The valuation chart above sets each month-end's price against the latest annual net income instead, so its latest point (about 21.9× as of Nov '26) can differ. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.